Actively Recruiting
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Led by National Cancer Center, Japan · Updated on 2024-03-22
1000
Participants Needed
18
Research Sites
434 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing. The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
CONDITIONS
Official Title
Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a histological diagnosis of rare cancer, cancer of unknown primary origin, or cancer of rare tissue subtypes of common cancers (defined in protocol)
- Patients with advanced stage cancer
- Adults aged 18 years or older
You will not qualify if you...
- Patients with complications of cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 18 locations
1
National Cancer Center Hospital, Japan
Chuo-ku, Tokyo, Japan, 104-0045
Actively Recruiting
2
Hospital Sultan Ismail
Johor Bahru, Johor, Malaysia
Actively Recruiting
3
Hospital Pulau Pinang
Pulau Pinang, Pulau Pinang, Malaysia
Actively Recruiting
4
Sarawak General Hospital
Kuching, Sarawak, Malaysia, 93586
Actively Recruiting
5
Hospital Kuala Lumpur
Kuala Lumpur, Malaysia, 50586
Actively Recruiting
6
University Malaya Medical Center
Kuala Lumpur, Malaysia
Actively Recruiting
7
Institut Kanser negara
Putrajaya, Malaysia, 62250
Actively Recruiting
8
St. Luke's Medical Center
Manila, Philippines, 1102
Actively Recruiting
9
National Cancer Center Korea
Seoul, South Korea
Actively Recruiting
10
National Taiwan University Hospital
Taipei, Zhongzheng, Taiwan, 100225
Actively Recruiting
11
Taipei Veterans General Hospital
Taipei, Taiwan
Actively Recruiting
12
Mahidol University by Faculty of Medicine, Ramathibodi Hospita
Bangkok, Thailand
Actively Recruiting
13
Mahidol University by Faculty of Medicine, Siriraj Hospital
Bangkok, Thailand
Actively Recruiting
14
Maharaj Nakorn Chiang Mai Hospital
Chiang Mai, Thailand
Not Yet Recruiting
15
Faculty of Medicine, Prince of Songkla University
Hat Yai, Thailand
Actively Recruiting
16
Khon Kaen University by Faculty of Medicine, Srinagarind Hospital
Khon Kaen, Thailand
Actively Recruiting
17
National Cancer Vietnam
Hanoi, Vietnam
Actively Recruiting
18
Ho Chi Minh City Oncology Hospital
Ho Chi Minh City, Vietnam
Not Yet Recruiting
Research Team
C
Chiharu Mizoguchi, MD
CONTACT
H
Hitomi Okuma, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here